Dacryocystorhinostomy with Intraoperative Mitomycin C.
- Author:
Ki Sook LEE
1
;
Young Ja BYUN
Author Information
1. Department of Ophthalmology, Seoul Adventist Hospital, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Endoscopic transnasal DCR;
Granuloma;
Mitomycin C
- MeSH:
Dacryocystorhinostomy*;
Fibroblasts;
Granuloma;
Humans;
Lacrimal Apparatus Diseases;
Mitomycin*;
Ophthalmology;
Osteotomy;
Seoul
- From:Journal of the Korean Ophthalmological Society
1998;39(9):1909-1914
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Nowadays endscopic transnasal dacryocystorhinostomy(DCR) has been done popularly in patients who had epiphora chronically because of lacrimal obstruction. The most frequent cause of DCR failure is obstruction of osteotomy site due to formation of granuloma. We used the mitomycin C to suppress proliferation of fibroblast to increase success rate. Between July 1996 and september 1997, 15 patients(16 eyes) who had visited ophthalmology department in Seoul Advantist Hospital made went endoscopic transnasal DCR and packed merocel socked with 0.2mg/ml between 3 months to 18 months(mean 11.5 months). One case showed recurrent epiphora 2 months after surgery, and success rate was 94%. In conclusion, endoscopic transnasal DCR with Mitomycin C should be considered to suppress proliferation of granuloma and increase success rate.
